Confirmed Exhibitors and Sponsors
For over 130 years, Abbott has been committed to helping people live their best possible life through the power of health. Abbott’s broad portfolio of science-based nutrition products nourish at every stage of life. Our research is focused on specific health areas, such as the prevention and management of muscle mass loss through specialized nutrition. The Abbott Nutrition Health Institute (ANHI) connects and empowers people through science-based nutrition resources to optimize health worldwide. ANHI presents the latest science by partnering with leading nutrition experts to provide education you can trust.
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company develops innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has 65,000 employees and a presence in virtually every country around the world to address some of the most challenging global health issues. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. Visit: www.bd.com
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Product portfolio: I.V. generic drugs, infusion therapies and clinical nutrition products as well as the related devices. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies. For more information, visit www.fresenius-kabi.com.
The Swiss family owned company Geistlich Pharma develops and produces pharmaceutical and medical devices since 1851 with a worldwide distribution and provides valuable assistance in solving medical issues. Products such as the antimicrobial catheter lock solution TauroSept® for the prevention and treatment of CRBSIs, originate from the company’s own research facilities in Central Switzerland.
Founded in 2011, Nestlé Health Science (NHSc) is a globally recognized leader in the field of nutritional science, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer health, medical nutrition and supplement brands.
NHSc is headquartered in Switzerland and we have more than 5,000 employees around the world, with a presence in 66 countries.
Approximately half of our business is dedicated to medical nutrition (products that are available only through healthcare providers) and half is dedicated to consumer care, or over-the-counter, nutritional solutions. We cover the spectrum from newborns to the most senior citizens, from individuals looking to enhance their fitness performance to those that need extra special nutritional care due to illnesses. For more information, please visit: www.nestlehealthscience.com
Since 1896, Nutricia has pioneered nutritional solutions that help people live longer, more joyful and healthier lives. Building on more than a century of research and innovation, Nutricia has created a leading specialized nutrition portfolio.
With its nutritional solutions, Nutricia helps to address some of the world’s health challenges including age-related conditions and chronic diseases, such as frailty, cancer, stroke and early Alzheimer’s disease.
Nutricia is part of Danone, a global leader with a unique health-focused portfolio in food and beverages.
VectivBio is a global, clinical-stage biotechnology company focused on developing transformational therapeutics for patients living with serious, rare diseases. The company is committed to pursuing rare diseases with well-defined biology that can be targeted with best-in-disease therapies that have the potential to meaningfully improve the lives of patients and their families. VectivBio’s lead investigational program, apraglutide, is a next-generation, long-acting GLP-2 analog for the treatment of short bowel syndrome (SBS). A Phase 3 trial of apraglutide is expected to begin before the end of 2020.
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery, development, and commercialization of next generation peptide-based medicines that change the lives of people living with metabolic and gastrointestinal diseases. Zealand’s robust pipeline of investigational medicines includes three candidates in late stage development, and one candidate being reviewed for regulatory approval in the United States. Zealand was founded in 1998 in Copenhagen, Denmark, and has presence throughout the U.S. that includes key locations in New York, Boston, and Marlborough (MA).